IMO, Data was "very close", why? Based upon UCLA f
Post# of 148188
Unblinded could lead to numerous approvals in other countries for s/c.
No unblinding, we still should obtain m/m approvals in some countries.
No unblinding means for s/c, wait many days for the 75% Interim analysis and then apply for FDA approval and then wait more day, as vaccines and competitive treatments move forward.
I am 70/30 for yes unblinding.